Akihiro Inazu

6.3k citations

136 papers · 4.9k indexed · 1 hit paper · h-index 38

Surgery top 0.5%
Endocrinology, Diabetes and Metabolism top 0.5%
Cancer Research top 2%
Cardiology and Cardiovascular Medicine top 2%
Molecular Biology top 10%

Co-authors: Hiroshi Mabuchi Atsushi Nohara Junji Koizumi Masa‐aki Kawashiri Junji Kobayashi Alan R. Tall Masakazu Yamagishi Hayato Tada
Topics: Lipoproteins and Cardiovascular Health (73 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers)Cancer, Lipids, and Metabolism (35 papers)
Cited by: Endocrinology, Diabetes and Metabolism Surgery Cancer Research
Journals: Nature New England Journal of Medicine Circulation
Partner nations: Japan United States Australia

In The Last Decade

Akihiro Inazu

134 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation

1990 687 citations Akihiro Inazu, Junji Koizumi et al. profile →

Peers

Countries citing papers authored by Akihiro Inazu

Since Specialization

Citations

This map shows the geographic impact of Akihiro Inazu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Inazu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Inazu more than expected).

Fields of papers citing papers by Akihiro Inazu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Inazu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Inazu. The network helps show where Akihiro Inazu may publish in the future.

Co-authorship network of co-authors of Akihiro Inazu

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Inazu. A scholar is included among the top collaborators of Akihiro Inazu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Inazu. Akihiro Inazu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A teenager boy with a novel variant of Sitosterolemia presented with pancytopenia 2022 ·Clinica Chimica Acta ·(unknown),Hayato Tada,(unknown),(unknown),(unknown),Alper Özcan,Ebru Yılmaz,Fatih Kardaş,Musa Karakükçü,Halit Canatan,Çiğdem Karakükçü,Munis Dündar,Akihiro Inazu,Ekrem Ünal	5
2	Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease 2018 ·Journal of clinical lipidology ·Hayato Tada,Masa‐aki Kawashiri,Akihiro Nomura,Ryota Teramoto,Kazuyoshi Hosomichi,Atsushi Nohara,Akihiro Inazu,Hiroshi Mabuchi,Atsushi Tajima,Masakazu Yamagishi	84
3	LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS 2016 ·Journal of the American College of Cardiology ·Hayato Tada,Masa‐aki Kawashiri,Atsushi Nohara,Akihiro Inazu,Hiroshi Mabuchi,Masakazu Yamagishi	1
4	Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia 2015 ·JIMD Reports ·Masa‐aki Kawashiri,Hayato Tada,(unknown),Matsuo Taniyama,Takamitsu Nakano,Katsuyuki Nakajima,Takeshi Inoue,Mika Mori,Chiaki Nakanishi,Tetsuo Konno,Kenshi Hayashi,Atsushi Nohara,Akihiro Inazu,Junji Koizumi,(unknown),Junji Kobayashi,Tsutomu Hirano,Hiroshi Mabuchi,Masakazu Yamagishi	11
5	Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation 2014 ·Atherosclerosis ·Hiroshi Mabuchi,Atsushi Nohara,Tohru Noguchi,Junji Kobayashi,Masa‐aki Kawashiri,Takeshi Inoue,Mika Mori,Hayato Tada,Chiaki Nakanishi,Kunimasa Yagi,Masakazu Yamagishi,Kousei Ueda,Tadayoshi Takegoshi,Susumu Miyamoto,Akihiro Inazu,Junji Koizumi	64
6	Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects 2011 ·Clinica Chimica Acta ·(unknown),Akihiro Inazu,Yoshihiro Noji,Takanobu WAKASUGI,Kenji Miwa,Hayato Tada,Masa‐aki Kawashiri,Tohru Noguchi,Atsushi Nohara,Junji Kobayashi,Junji Koizumi,Masakazu Yamagishi,Hiroshi Mabuchi	12
7	Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan 2010 ·Atherosclerosis ·Hiroshi Mabuchi,Atsushi Nohara,Tohru Noguchi,Junji Kobayashi,Masa‐aki Kawashiri,Hayato Tada,Chiaki Nakanishi,Mika Mori,Masakazu Yamagishi,Akihiro Inazu,Junji Koizumi	82
8	Difference between Fasting and Nonfasting Triglyceridemia; the Influence of Waist Circumference 2009 ·Journal of Atherosclerosis and Thrombosis ·Rie Oka,Junji Kobayashi,Katsuyuki Miura,Shin‐ya Nagasawa,Tadashi Moriuchi,Senshu Hifumi,Susumu Miyamoto,Masa‐aki Kawashiri,Atsushi Nohara,Akihiro Inazu,Yoshiyu Takeda,Hiroshi Mabuchi,Kunimasa Yagi,Masakazu Yamagishi	16
9	A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma 2008 ·Journal of Lipid Research ·Shigeyuki Imamura,Jun Kobayashi,Katsuyuki Nakajima,Shin‐ichi Sakasegawa,Atsushi Nohara,Tohru Noguchi,Masa‐aki Kawashiri,Akihiro Inazu,S S Deeb,Hiroshi Mabuchi,John D. Brunzell	29
10	A novel method for measuring human hepatic lipase activity in postheparin plasma 2006 ·Journal of Lipid Research ·Shigeyuki Imamura,Junji Kobayashi,Shin‐ichi Sakasegawa,Atsushi Nohara,Katsuyuki Nakajima,Masa‐aki Kawashiri,Akihiro Inazu,Masakazu Yamagishi,Jun‐ichi Koizumi,Hiroshi Mabuchi	9
11	Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients 2005 ·Journal of Atherosclerosis and Thrombosis ·Hiroshi Mabuchi,Toshinori Higashikata,Masa‐aki Kawashiri,Shoji Katsuda,Mihoko Mizuno,Atsushi Nohara,Akihiro Inazu,Junji Koizumi,Junji Kobayashi	97
12	Long-Term Course of Lipoprotein Lipase (LPL) Deficiency Due to Homozygous LPL_Aritain a Patient with Recurrent Pancreatitis, Retained Glucose Tolerance, and Atherosclerosis 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Masa‐aki Kawashiri,Toshinori Higashikata,Mihoko Mizuno,(unknown),Shoji Katsuda,Kenji Miwa,Tsuyoshi Nozue,Atsushi Nohara,Akihiro Inazu,Junji Kobayashi,Junji Koizumi,Hiroshi Mabuchi	30
13	Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese 2002 ·Atherosclerosis ·Yuri Moriyama,Tomonori Okamura,Kouji Kajinami,Hiroyasu Iso,Akihiro Inazu,Masa‐aki Kawashiri,Mihoko Mizuno,(unknown),Yasuki Sakamoto,(unknown),(unknown),Hiroshi Mabuchi	47
14	Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population 2002 ·Atherosclerosis ·Wenxin Yu,Atsushi Nohara,Toshinori Higashikata,Hong Lü,Akihiro Inazu,Hiroshi Mabuchi	59
15	Effects of hepatic lipase gene promoter nucleotide variations on serum HDL cholesterol concentration in the general Japanese population 2001 ·Journal of Human Genetics ·Akihiro Inazu,Y Nishimura,Yasuko Terada,Hiroshi Mabuchi	26
16	Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia 2000 ·The American Journal of Cardiology ·Masa‐aki Kawashiri,Kouji Kajinami,Atsushi Nohara,Kunimasa Yagi,Akihiro Inazu,Junji Koizumi,Hiroshi Mabuchi	25
17	Enzyme immunoassay for cholesteryl ester transfer protein in human serum 1998 ·Clinica Chimica Acta ·(unknown),(unknown),(unknown),Akihiro Inazu,Junji Koizumi,Hiroshi Mabuchi,Kenji Chichibu	31
18	Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. 1994 ·Journal of Clinical Investigation ·Akihiro Inazu,Xian‐Cheng Jiang,Tatsuo Haraki,Kunimasa Yagi,(unknown),Jun‐ichi Koizumi,Hiroshi Mabuchi,R Takeda,Kazuhide Takata,Yuri Moriyama	198
19	Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia 1993 ·Atherosclerosis ·Junji Koizumi,(unknown),(unknown),Akihiro Inazu,(unknown),Tatsuo Haraki,Kunimasa Yagi,(unknown),Susumu Miyamoto,Tadayoshi Takegoshi,Hiroshi Mabuchi,Ryoyu Takeda,Nobutaka Tani,Satoshi Takada	36
20	Novel gene mutations at the low density lipoprotein receptor locus: FH‐Kanazawa and FH‐Okayama 1990 ·Journal of Internal Medicine ·(unknown),Hiroshi Mabuchi,Akihiro Inazu,Hideaki Fujita,Jun‐ichi Koizumi,R Takeda,(unknown),(unknown)	8

About Akihiro Inazu

Akihiro Inazu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 136 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (73 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers) and Cancer, Lipids, and Metabolism (35 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Surgery (3.1k citations) and Cancer Research (1.1k citations). Akihiro Inazu has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hiroshi Mabuchi, Atsushi Nohara, Junji Koizumi, Masa‐aki Kawashiri, Junji Kobayashi, Alan R. Tall, Masakazu Yamagishi, Hayato Tada, Maryanne L. Brown and Luis B. Agellon. Their work appears in journals such as Nature, New England Journal of Medicine and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact